HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever

This article was originally published in The Rose Sheet

Executive Summary

Advertising efforts shift to emphasize 400 core brands rather than previous 1,600 in order to allocate more spending to top revenue producers, firm says. Brands such as Dove and Suave will benefit from change with higher ad budgets, while brands that do not rank in top two within their category will be marketed without promotions, divested or will cease to be manufactured within four years, company says. Strategy is part of portfolio restructuring announced in 1999 (1"The Rose Sheet" Sept. 27, 1999, p. 8). Unilever already has divested more than half of proposed 1,200 brands to be disposed. Additional 8,000 job cuts, 30 factory closings announced during recent analyst call. New round of cuts, primarily related to Best Foods acquisition, in addition to 25,000 announced last year

Latest Headlines
See All
UsernamePublicRestriction

Register

RS009206

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel